Resistant Hypertension Management

Definition and Diagnosis

Resistant hypertension is defined as blood pressure that remains above target (>130/80 mmHg) despite concurrent use of at least three antihypertensive agents of different classes at maximal or maximally tolerated doses, or BP control requiring four or more drugs, according to the American Heart Association 3, 2
True resistant hypertension must be distinguished from pseudoresistance by confirming with 24-hour ambulatory blood pressure monitoring to exclude white-coat effect, as recommended by the American College of Cardiology 1, 2
Assessing medication adherence is crucial, as it accounts for approximately 50% of apparent treatment resistance, according to the American Journal of Kidney Diseases 4, 2
Ruling out interfering substances (NSAIDs, oral contraceptives, stimulants) is necessary, as suggested by the American Journal of Kidney Diseases 4, 2

The American College of Cardiology recommends implementing dietary sodium restriction to less than 2400 mg/day as part of lifestyle modifications for resistant hypertension 1, 2
Encouraging weight loss for overweight/obese patients is recommended, as stated by the American College of Cardiology 1, 2
Increasing physical activity with a structured exercise program is suggested, according to the American Journal of Kidney Diseases 4
Limiting alcohol consumption (≤2 drinks/day for men, ≤1 drink/day for women) is advised, as recommended by the American Journal of Kidney Diseases 4
Considering the DASH diet can facilitate achieving desirable weight, according to the American Journal of Kidney Diseases 4
Adding spironolactone 25mg daily as the fourth agent has demonstrated superior efficacy in resistant hypertension, as stated by the American College of Cardiology 1, 2
Monitoring serum potassium and renal function 1-2 weeks after initiating spironolactone is necessary, particularly with existing RAS blockade, as recommended by the American College of Cardiology 1, 2

Screening all patients with resistant hypertension for primary aldosteronism (even with normal potassium levels) is recommended, according to the American Heart Association 3, 1
Screening for obstructive sleep apnea is suggested, as stated by the American Heart Association 5, 6
Screening for chronic kidney disease is necessary, according to the American Journal of Kidney Diseases 4, 2
Screening for renal artery stenosis is recommended, as stated by the American College of Cardiology 1
Screening for other endocrine disorders is suggested, according to the American College of Cardiology 1

For Black patients, ensuring the regimen includes a diuretic or calcium channel blocker is recommended, as stated by the American College of Cardiology 2
In patients with heart failure, including ACE inhibitor/ARB, beta-blocker, and mineralocorticoid receptor antagonist is suggested, according to the American College of Cardiology 2

Assessing blood pressure response within 2-4 weeks of medication adjustment is recommended, as stated by the American College of Cardiology 1
Monitoring serum potassium and renal function regularly, especially after initiating spironolactone, is necessary, according to the American College of Cardiology 1
Considering home blood pressure monitoring can guide medication titration and improve adherence, as suggested by the American Heart Association 3

Failing to confirm true resistant hypertension before escalating therapy is a common pitfall, as stated by the American Journal of Kidney Diseases 4, 2
Inadequate diuretic therapy leading to volume overload is a common mistake, according to the American College of Cardiology 2
Not screening for secondary causes, particularly primary aldosteronism, is a common oversight, as recommended by the American Heart Association 3, 1
Overlooking medication non-adherence as a cause of apparent resistance is a common error, according to the American Journal of Kidney Diseases 4, 2
Using suboptimal medication combinations or inadequate doses is a common pitfall, as stated by the American College of Cardiology 2